Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Oncology

Life After Treatment: Surveillance and Your Future Health

At a Glance

After DFSP treatment, long-term surveillance is crucial because the tumor can grow back at the original site. Patients should attend regular clinical exams, perform monthly scar checks for new bumps or color changes, and communicate with their oncology team to manage any anxiety.

After the physical removal of a Dermatofibrosarcoma protuberans (DFSP) tumor, you enter the surveillance phase. Because DFSP is known for its ability to grow back in the same spot—even years after a successful surgery—long-term monitoring is the cornerstone of your survivorship [1][2][3].

The Risk of Recurrence

The goal of surveillance is to catch a local recurrence (the tumor returning at the original site) as early as possible. While the risk of the cancer spreading to other organs is very low for most patients, the risk of it returning to the skin is real due to its “tentacle-like” growth pattern [2][4].

  • Classic DFSP: Primarily carries a risk of local recurrence. It very rarely spreads through the body [1][2].
  • Fibrosarcomatous DFSP (FS-DFSP): This more aggressive variant has a higher risk of both local recurrence and metastasis (spreading), usually to the lungs [5][6][7].

Recommended Surveillance Schedule

Your follow-up plan is not “one-size-fits-all.” It is based on your specific subtype and how your surgery went. While expert opinions vary, most doctors follow a pattern similar to this:

Feature Classic DFSP Fibrosarcomatous (FS-DFSP)
Clinical Exam Every 6 months for the first 5 years; then annually [8]. Every 3–6 months for the first 2–3 years; then annually [9][10].
Chest Imaging Generally not required unless symptoms appear [9]. Periodic Chest CT scans to check the lungs [7][10].
Duration Long-term; many doctors suggest 10 years or more [3][11]. Long-term or indefinite, similar to high-grade sarcomas [9][10].

Monitoring Your Surgical Site

In between doctor visits, you are the most important member of your care team. Perform a monthly self-check of your surgical scar and the surrounding area.

Pro-Tip: Take clear, baseline photographs of your healed scar in good lighting. This provides a reliable visual reference to help you and your doctor identify any subtle changes over the years.

Look and feel for:

  • New Nodules: Any new, firm bumps or lumps on or near the scar [12].
  • Texture Changes: Persistent thickening or a “rubbery” feel to the skin [13].
  • Color Changes: Any new reddish, blue, or brownish discoloration [13][14].

Managing “Scanxiety” and Emotional Health

It is completely normal to feel a surge of anxiety in the days or weeks leading up to a follow-up appointment or imaging scan—a phenomenon often called scanxiety [15].

While DFSP is highly treatable, the need for long-term monitoring can be stressful. However, try to reframe surveillance as a proactive tool that keeps you safe, rather than a constant reminder of the disease.

Many survivors find the following strategies helpful in managing fear of cancer recurrence:

  • Mindfulness and Relaxation: Techniques like deep breathing or meditation can help calm the nervous system during stressful periods [16][17].
  • Cognitive Behavioral Therapy (CBT): Working with a therapist can help you “reframe” anxious thoughts and develop healthy coping mechanisms [16][18].
  • Support Groups: Connecting with others who have rare sarcomas can reduce the feeling of isolation [15].

If your anxiety begins to interfere with your daily life or sleep, do not hesitate to ask your oncology team for a referral to a mental health professional who specializes in supporting cancer survivors [19][15].

Common questions in this guide

How often do I need follow-up exams after DFSP treatment?
Most patients with classic DFSP need clinical skin exams every 6 months for the first 5 years, and then annually. If you have the fibrosarcomatous variant, exams are usually more frequent, such as every 3 to 6 months for the first few years.
What should I look for when checking my DFSP surgical scar?
Check your scar and the surrounding area monthly for any new firm bumps, persistent skin thickening, or new red, blue, or brown discoloration. Taking baseline photos of your fully healed scar can help you and your doctor spot subtle changes over time.
Do I need routine chest scans after DFSP surgery?
Routine chest scans are generally not required for classic DFSP unless new symptoms appear. However, patients with Fibrosarcomatous DFSP usually need periodic chest CT scans because this subtype has a higher risk of spreading to the lungs.
What is scanxiety and how can I manage it?
Scanxiety is the normal surge of anxiety you may feel leading up to follow-up appointments or imaging tests. You can manage it by reframing surveillance as a proactive safety tool, practicing mindfulness, or working with a therapist for coping strategies.
Will my DFSP ever be considered completely cured?
Because DFSP has "tentacle-like" roots and can recur at the original site even years after successful surgery, long-term monitoring is required. Many doctors recommend surveillance for 10 years or even indefinitely depending on your specific tumor characteristics.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my specific pathology (Classic vs. FS-DFSP), what is your recommended schedule for follow-up exams?
  2. 2.Do I need any routine imaging, such as a chest CT, and if so, how often?
  3. 3.What exactly should I be looking and feeling for at my surgical site during self-exams?
  4. 4.At what point would you consider me 'cured,' or will I need monitoring indefinitely?
  5. 5.Can you recommend any resources or professionals to help manage the anxiety I feel before my follow-up appointments?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Wide local excision vs. Mohs Tübingen technique in the treatment of dermatofibrosarcoma protuberans: a two-centre retrospective study and literature review.

    Veronese F, Boggio P, Tiberio R, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2017; (31(12)):2069-2076 doi:10.1111/jdv.14378.

    PMID: 28573714
  2. 2

    Dermatofibrosarcoma Protuberans.

    Allen A, Ahn C, Sangüeza OP

    Dermatologic clinics 2019; (37(4)):483-488 doi:10.1016/j.det.2019.05.006.

    PMID: 31466588
  3. 3

    Dermatofibrosarcoma Protuberans.

    Reha J, Katz SC

    The Surgical clinics of North America 2016; (96(5)):1031-46.

    PMID: 27542641
  4. 4

    Role of diffusion-weighted magnetic resonance imaging in the evaluation of scalp dermatofibrosarcoma protuberans.

    Van Steenkiste E, Van Laethem A, Biesemans G, Pans S

    International journal of dermatology 2016; (55(2)):226-31 doi:10.1111/ijd.13050.

    PMID: 26712720
  5. 5

    Dermatofibrosarcoma protuberans: A clinical analysis.

    Lyu A, Wang Q

    Oncology letters 2018; (16(2)):1855-1862 doi:10.3892/ol.2018.8802.

    PMID: 30008876
  6. 6

    Dermatofibrosarcoma Protuberans: An Updated Review of the Literature.

    Jozwik M, Bednarczuk K, Osierda Z

    Cancers 2024; (16(18)) doi:10.3390/cancers16183124.

    PMID: 39335097
  7. 7

    Pulmonary metastasis of dermatofibrosarcoma protuberans.

    Cao Q, Zhang C, Li L, et al.

    Pulmonology 2025; (31(1)):2498280 doi:10.1080/25310429.2025.2498280.

    PMID: 40439178
  8. 8

    Dermatofibrosarcoma Protuberans Over Right Lumbar Region: A Case Report.

    Pathak B, Maimoon S

    Cureus 2023; (15(1)):e33208 doi:10.7759/cureus.33208.

    PMID: 36733580
  9. 9

    Outcome After Surgical Treatment of Dermatofibrosarcoma Protuberans (DFSP): Does it Require Extensive Follow-up and What is an Adequate Resection Margin?

    Alshaygy I, Mattei JC, Basile G, et al.

    Annals of surgical oncology 2023; (30(5)):3106-3113 doi:10.1245/s10434-022-12953-8.

    PMID: 36658251
  10. 10

    Metastatic Fibrosarcomatous Transformation of Dermatofibrosarcoma Protuberans With Lung Metastasis: A Case Report.

    Khan S, Yetiskul E, Niazi M, et al.

    Cureus 2024; (16(5)):e59742 doi:10.7759/cureus.59742.

    PMID: 38841035
  11. 11

    Risk-stratified surveillance in dermatofibrosarcoma protuberans: Less is more.

    Gladdy RA, Wunder JS

    Cancer 2019; (125(5)):670-672 doi:10.1002/cncr.31922.

    PMID: 30644529
  12. 12

    Bednar's tumor at right shoulder in an adult male: a case report of a rare entity.

    Acharya B, Yadav DK, Chetry A, et al.

    Annals of medicine and surgery (2012) 2024; (86(2)):1196-1199 doi:10.1097/MS9.0000000000001672.

    PMID: 38333248
  13. 13

    Primary scalp dermatofibrosarcoma protuberans with periosteal involvement.

    Steele L, Mitchell C, Sharma S, Keohane SG

    Clinical and experimental dermatology 2020; (45(5)):661-663 doi:10.1111/ced.14166.

    PMID: 31960488
  14. 14

    Dermatofibrosarcoma Protuberans Secondary to a Decorative Tattoo: An Isotattootopic Response?

    Lastrucci I, Gunnella S, Pileri A, et al.

    Indian journal of dermatology 2018; (63(5)):439-440 doi:10.4103/ijd.IJD_265_17.

    PMID: 30210175
  15. 15

    Examining fear of cancer recurrence in primary brain tumor patients and their caregivers using the Actor-Partner Interdependence Model.

    Braun SE, Aslanzadeh FJ, Thacker L, Loughan AR

    Psycho-oncology 2021; (30(7)):1120-1128 doi:10.1002/pon.5659.

    PMID: 33599334
  16. 16

    Therapeutic intervention in fear of cancer recurrence in adult oncology patients: a systematic review.

    Paperák P, Javůrková A, Raudenská J

    Journal of cancer survivorship : research and practice 2023; (17(4)):1017-1035 doi:10.1007/s11764-022-01277-x.

    PMID: 36307611
  17. 17

    Mind-body interventions for fear of cancer recurrence: A systematic review and meta-analysis.

    Hall DL, Luberto CM, Philpotts LL, et al.

    Psycho-oncology 2018; (27(11)):2546-2558 doi:10.1002/pon.4757.

    PMID: 29744965
  18. 18

    Development and usability evaluation of an online self-management intervention for fear of cancer recurrence (iConquerFear).

    Smith AB, Bamgboje-Ayodele A, Butow P, et al.

    Psycho-oncology 2020; (29(1)):98-106 doi:10.1002/pon.5218.

    PMID: 31483911
  19. 19

    Guidelines needed for the management of fear of cancer recurrence in adult survivors of cancer in the United States: A consensus statement.

    Hall DL, Wagner LI, Lebel S, et al.

    Cancer 2024; (130(16)):2739-2742 doi:10.1002/cncr.35326.

    PMID: 38630904

This page provides general surveillance guidelines for DFSP survivors for educational purposes only. Always follow the specific, personalized follow-up schedule designed by your oncology team.

Get notified when new evidence is published on Dermatofibrosarcoma protuberans.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.